Kirsch Arthur S
- SEC CIK
- 0001290976
In the past year, 1 open-market purchase filing worth $133.0K and 1 sale filing worth $1.73M.
Current role at each company
- EVMN Evommune, Inc.Directoras of Jul 8, 2026
- AVIR Atea Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- LQDA Liquidia CorpDirectoras of Jun 18, 2026
- KDMN Kadmon Holdings, Inc.Directoras of Nov 9, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $133.0K
- 1 filing
- Sold
- $1.73M
- 1 filing
- Net
- −$1.60M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Kirsch Arthur S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EVMN Evommune, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 (view filing)8:00 PM ET | Jul 7 | 1 day | Kirsch Arthur SDirector | PPurchase | +10.0K | $13.30 | +$133.0K | New position10.0K after |
LQDA Liquidia Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 (view filing) | Jun 1-3 | 2 days | Kirsch Arthur SDirector | SSale | −30.0K | $57.71 | −$1.73M | −100.0%0 after | 3 lots |
| Nov 12, 2021 (view filing) | Nov 10 | 2 days | Kirsch Arthur SDirector | PPurchase | +30.0K | $4.24 | +$127.2K | +1,500.0%32.0K after |